Introducing ADI’s new CEO: Dr. Faith Mwangi-Powell
ADI announces our new CEO, joining on 1 October 2026
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
ADI announces our new CEO, joining on 1 October 2026
In this guest article, ADI Board Member and dementia advocate, Bill Yeates, shares his post diagnosis journey, discussing the hopes and challenges of life between scans.
On Young Carers Awareness Day, ADI Communications and Policy Manager, Annie Bliss, highlights some global examples of youth engagement in issues around dementia. Youth participation is critical for dementia communities globally, as young people play a huge role in volunteerism, advocacy and raising awareness.
Meera Pattabiraman, Chair of Alzheimer’s Disease and Related Disorders Society of India (ARDSI), writes about ARDSI’s successful engagements with the Ministry of Health and Family Welfare in India, a country where over 5 million people live with dementia.
Featured in the World Alzheimer Report 2019: Attitudes to dementia, Rangimahora Reddy and Pare Meha of the Rauawaawa Kaumātua Charitable Trust, as well as Dr Etuini Ma’u of the Waikato District Health Board and Professor John Oetzel of the University of Waikato, delve into the complexities surrounding diagnosing mate wareware (dementia) in Māori communities and how tailored cultural programmes can aid in supporting the individual and their whānau (family).
In this case study excerpt for the World Alzheimer Report 2019, Maree McCabe, CEO of Dementia Australia, writes about the importance of culturally sensitive diagnostic methods when addressing dementia within Indigenous Australian communities.
In this case study excerpt for the World Alzheimer Report 2019, María Cecilia López Murga, Executive of Asociación Group Ermita Alzheimer de Guatemala, writes about how the association's mission to address the challenges around dementia within Guatemala’s Indigenous communities.
In this case study excerpt for the World Alzheimer Report 2019, Kristen Jacklin and Karen Pitawanakwat write about understanding the experiences of dementia within Indigenous communities in order to meet dementia care needs in a culturally sensitive way.
In 2016 Spominčica – Alzheimer Slovenija started developing the Dementia Friendly Spots (DFS) programme. It is a national education and awareness-raising programme connecting a wide spectrum of organisations in a network of sites providing information about dementia locally. The network of DFS include: police and fire stations, shops, libraries,…
hinese Pharmaceutical Company Green Valley announces their drug Oligomannate (GV-971) has been granted conditional approval for the treatment of "mild to moderate Alzheimer's disease".